R K Avery

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi request reprint Immunizations in adult immunocompromised patients: which to use and which to avoid
    R K Avery
    Department of Infectious Diseases and Transplant Center, Cleveland Clinic, USA
    Cleve Clin J Med 68:337-48. 2001
  2. ncbi request reprint Infections after lung transplantation
    Robin K Avery
    Department of Infectious Disease, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Semin Respir Crit Care Med 27:544-51. 2006
  3. ncbi request reprint Listeria monocytogenes tricuspid valve endocarditis with septic pulmonary emboli in a liver transplant recipient
    R K Avery
    Department of Infectious Disease and Transplant Center, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Transpl Infect Dis 1:284-7. 1999
  4. ncbi request reprint Special considerations regarding CMV in lung transplantation
    R K Avery
    Department of Infectious Diseases and Transplant Center, Cleveland Clinic Foundation, Ohio 44195, USA
    Transpl Infect Dis 1:13-8. 1999
  5. ncbi request reprint Recipient screening prior to solid-organ transplantation
    Robin K Avery
    Department of Infectious Diseases and Transplant Center, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Clin Infect Dis 35:1513-9. 2002
  6. doi request reprint Influenza vaccines in the setting of solid-organ transplantation: are they safe?
    Robin K Avery
    Department of Infectious Disease, Medicine Institute, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA
    Curr Opin Infect Dis 25:464-8. 2012
  7. ncbi request reprint Prophylactic measures in the solid-organ recipient before transplantation
    R K Avery
    Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, OH, USA
    Clin Infect Dis 33:S15-21. 2001
  8. ncbi request reprint Aspergillosis in hematopoietic stem cell transplant recipients: risk factors, prophylaxis, and treatment
    Robin K Avery
    Transplant Infectious Disease Adult, Cleveland Clinic Department of Infectious Disease, Cleveland Clinic Lerner College of Medicine, Desk S 32, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Infect Dis Rep 11:223-8. 2009
  9. ncbi request reprint Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection
    R K Avery
    Department of Infectious Disease, Cleveland Clinic Foundation, Desk S 32, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Bone Marrow Transplant 34:1071-5. 2004
  10. doi request reprint Utility of leflunomide in the treatment of complex cytomegalovirus syndromes
    Robin K Avery
    Department of Infectious Disease, Medicine Institute, The Cleveland Clinic, Cleveland, OH, USA
    Transplantation 90:419-26. 2010

Collaborators

Detail Information

Publications50

  1. ncbi request reprint Immunizations in adult immunocompromised patients: which to use and which to avoid
    R K Avery
    Department of Infectious Diseases and Transplant Center, Cleveland Clinic, USA
    Cleve Clin J Med 68:337-48. 2001
    ..Vaccines may sometimes induce suboptimal immunogenicity, but even partial protection may benefit severely ill patients...
  2. ncbi request reprint Infections after lung transplantation
    Robin K Avery
    Department of Infectious Disease, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Semin Respir Crit Care Med 27:544-51. 2006
    ..This review addresses the salient pathogens that may infect organ transplant recipients, and discusses strategies to prevent or treat specific pathogens in this highly susceptible patient population...
  3. ncbi request reprint Listeria monocytogenes tricuspid valve endocarditis with septic pulmonary emboli in a liver transplant recipient
    R K Avery
    Department of Infectious Disease and Transplant Center, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Transpl Infect Dis 1:284-7. 1999
    ..The possible relationship between susceptibility to Listeria infection and the discontinuation of trimethoprim-sulfamethoxazole prophylaxis is of interest...
  4. ncbi request reprint Special considerations regarding CMV in lung transplantation
    R K Avery
    Department of Infectious Diseases and Transplant Center, Cleveland Clinic Foundation, Ohio 44195, USA
    Transpl Infect Dis 1:13-8. 1999
    ....
  5. ncbi request reprint Recipient screening prior to solid-organ transplantation
    Robin K Avery
    Department of Infectious Diseases and Transplant Center, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Clin Infect Dis 35:1513-9. 2002
    ..Recommendations for pretransplant immunization and education are provided...
  6. doi request reprint Influenza vaccines in the setting of solid-organ transplantation: are they safe?
    Robin K Avery
    Department of Infectious Disease, Medicine Institute, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA
    Curr Opin Infect Dis 25:464-8. 2012
    ....
  7. ncbi request reprint Prophylactic measures in the solid-organ recipient before transplantation
    R K Avery
    Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, OH, USA
    Clin Infect Dis 33:S15-21. 2001
    ..All nonimmune pretransplant patients should be considered candidates for the varicella vaccine. The management of special risk groups is discussed in detail...
  8. ncbi request reprint Aspergillosis in hematopoietic stem cell transplant recipients: risk factors, prophylaxis, and treatment
    Robin K Avery
    Transplant Infectious Disease Adult, Cleveland Clinic Department of Infectious Disease, Cleveland Clinic Lerner College of Medicine, Desk S 32, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Infect Dis Rep 11:223-8. 2009
    ..Future directions include increasingly sophisticated risk stratification, clinical testing of combination therapies, and adjunctive immunomodulatory therapies...
  9. ncbi request reprint Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection
    R K Avery
    Department of Infectious Disease, Cleveland Clinic Foundation, Desk S 32, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Bone Marrow Transplant 34:1071-5. 2004
    ..However, the toxicity profile of leflunomide in patients with underlying GVHD remains to be defined...
  10. doi request reprint Utility of leflunomide in the treatment of complex cytomegalovirus syndromes
    Robin K Avery
    Department of Infectious Disease, Medicine Institute, The Cleveland Clinic, Cleveland, OH, USA
    Transplantation 90:419-26. 2010
    ..Leflunomide, a drug for rheumatoid arthritis, has been reported to have anti-CMV activity. This study reports on its use in 17 transplant recipients with complex CMV syndromes who had failed or were intolerant to other therapies...
  11. ncbi request reprint Prophylactic strategies before solid-organ transplantation
    Robin K Avery
    Department of Infectious Disease and Transplant Center, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Curr Opin Infect Dis 17:353-6. 2004
    ..This review will highlight developments with potential impact on donor and recipient screening and pretransplant management...
  12. doi request reprint Antifungal prophylaxis in lung transplantation
    Robin K Avery
    Department of Infectious Disease, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA
    Semin Respir Crit Care Med 32:717-26. 2011
    ..This review discusses the salient fungal organisms responsible for infection in lung transplant recipients and management strategies for prevention...
  13. doi request reprint Update in management of ganciclovir-resistant cytomegalovirus infection
    Robin K Avery
    Transplant Infectious Disease Section, The Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA
    Curr Opin Infect Dis 21:433-7. 2008
    ..The present review summarizes recent developments in pathogenesis, prevention, and management of ganciclovir-resistant cytomegalovirus infection...
  14. ncbi request reprint Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection
    C M Isada
    Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Transpl Infect Dis 4:189-94. 2002
    ..Ganciclovir-resistant (GCV-R) cytomegalovirus (CMV) is now being reported with increasing frequency in solid organ transplant recipients...
  15. ncbi request reprint Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation
    S B Mossad
    Department of Infectious Diseases, Cleveland Clinic Foundation, 9500 Euclid Avenue S-32, Cleveland, OH 44195, USA
    Bone Marrow Transplant 28:491-5. 2001
    ..The best strategy to prevent CMV in patients undergoing nonmyeloablative PBSCT remains to be determined, but strategies employed in traditional allogeneic bone marrow transplantation should be considered in these patients...
  16. ncbi request reprint Hypogammaglobulinemia in lung transplant recipients
    N S Goldfarb
    Transplant Center and Department of Pulmonary Medicine, Cleveland Clinic Foundation, OH 44195, USA
    Transplantation 71:242-6. 2001
    ..Immunoglobulin monitoring may offer an opportunity for intensive surveillance, tapering of immunosuppression, and preemptive therapy for infection...
  17. doi request reprint Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area
    J Cuellar-Rodríguez
    Departments of 1Infectious Diseases, 2Nephrology and Hypertension, 3Pulmonary and Critical Care Medicine, and 4Clinical Microbiology, Cleveland Clinic, Cleveland, Ohio, USA
    Clin Infect Dis 49:710-6. 2009
    ..Many clinical scenarios have been encountered by patients who developed histoplasmosis after receiving a solid organ transplant at a large transplant center in an endemic area...
  18. ncbi request reprint Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies
    S M Gordon
    Department of Infectious Disease, Infection Control, and Transplant Center, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Transpl Infect Dis 3:161-7. 2001
    ..Recent advances include prophylactic and pre-emptive antifungal strategies, newer therapeutic agents, and improved risk stratification...
  19. doi request reprint Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients
    R K Avery
    Infectious Diseases, The Cleveland Clinic, Cleveland, Ohio, USA
    Transpl Infect Dis 12:489-96. 2010
    ..Previous Phase I and II studies have demonstrated a favorable safety profile for MBV, but its utility in treatment of complex CMV syndromes is unknown...
  20. ncbi request reprint The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants
    A Minari
    Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Transpl Infect Dis 4:195-200. 2002
    ..Invasive aspergillosis (IA) is associated with significant morbidity and mortality in solid organ transplant recipients but data on the incidence rates stratified by type of solid organ are limited...
  21. ncbi request reprint Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection
    M H Yamani
    Department of Cardiology, Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    J Heart Lung Transplant 20:425-30. 2001
    ..IgG level may be a useful marker for identifying patients at high risk...
  22. doi request reprint Lung transplantation in a recipient with novel 2009 H1N1 influenza: lessons learned
    D P Mason
    Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Thorac Cardiovasc Surg 59:126-7. 2011
    ..Immunosuppressed patients are at an increased risk for severe disease from influenza A (H1N1). We report a case of a patient who died of septic complications from H1N1 acquired at the time of single lung transplant...
  23. ncbi request reprint Significance of positive cultures from donor left atrium and postpreservation fluid in heart transplantation
    S B Mossad
    Department of Infectious Diseases, Cleveland Clinic Foundation, Ohio 44195 5066, USA
    Transplantation 64:1209-10. 1997
    ..The significance of positive perioperative cultures routinely obtained from the donor left atrium and postpreservation fluid during heart transplantation is unknown...
  24. ncbi request reprint The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization
    R K Avery
    Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Bone Marrow Transplant 30:311-4. 2002
    ..We conclude that etoposide mobilization is associated with a significant incidence of neutropenic fever, which can be substantially reduced by a vigorous antimicrobial prophylactic program...
  25. ncbi request reprint Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based review
    K Ramasubbu
    Department of Infectious Disease, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Transpl Infect Dis 5:98-103. 2003
    ..Several potential causes have been identified in this setting, including viral infections and medications...
  26. ncbi request reprint Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued?
    S M Gordon
    Department of Infectious Diseases and Pulmonary Medicine, The Cleveland Clinic Foundation, Ohio 44195, USA
    Clin Infect Dis 28:240-6. 1999
    ..Extending the duration of PCP prophylaxis beyond 1 year may be warranted for lung transplant recipients...
  27. ncbi request reprint Infectious disease and transplantation: messages for the generalist
    R K Avery
    Department of Infectious Disease, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 65:305-14. 1998
    ..This paper reviews the primary care physician's role in the pretransplantation evaluation, and in coordination of long-term care, as well as illustrative cases...
  28. ncbi request reprint Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection
    S Mossad
    Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, OH, USA
    Bone Marrow Transplant 35:375-81. 2005
    ..Hospital readmission rates were similar in both groups. Steroid prophylaxis significantly decreases the risk of ES following AHSCT, and is associated with shortened hospitalization, without increasing risk of infection...
  29. ncbi request reprint Hypogammaglobulinemia after heart transplantation: impact of pre-emptive use of immunoglobulin replacement (CytoGam) on infection and rejection outcomes
    M H Yamani
    Departament of Cardiology, Cleveland Clinic Foundation, Ohio 44195, USA
    Transpl Infect Dis 3:40-3. 2001
    ..001) and episodes of rejection (grade > or = 3; P = 0.03 and grade > or = 2; P = 0.04) compared with the control group...
  30. ncbi request reprint Vaccination of the immunosuppressed adult patient with rheumatologic disease
    R K Avery
    Department of Infectious Diseases, Cleveland Clinic Foundation, Ohio, USA
    Rheum Dis Clin North Am 25:567-84, viii. 1999
    ..Vaccine-preventable diseases are a major cause of morbidity in immunocompromised patients. This article reviews the data on efficacy and safety of currently licensed vaccines in patients with rheumatologic diseases...
  31. ncbi request reprint Update on immunizations in solid organ transplant recipients: what clinicians need to know
    R K Avery
    Section Head, Transplant Infectious Diseases, Cleveland Clinic, Cleveland, OH, USA
    Am J Transplant 8:9-14. 2008
    ..Further studies will be important to determine the indications and optimal timing of newer immunizations and immunization strategies...
  32. pmc Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry
    Roy F Chemaly
    Department of Clinical Pathology, Section of Clinical Microbiology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Clin Microbiol 42:2168-72. 2004
    ..Both IHC and determination of the CMV viral load in BAL samples may be useful for the detection of individuals at risk for the development of fulminant invasive CMV disease...
  33. ncbi request reprint A case of zygomycosis and invasive candidiasis involving the epiglottis and tongue in an immunocompromised patient
    Roy F Chemaly
    Department of Infectious Diseases, The Cleveland Clinic Foundation, Ohio 44195, USA
    Scand J Infect Dis 34:149-51. 2002
    ....
  34. ncbi request reprint Ganciclovir-resistant cytomegalovirus disease in heart transplant recipients: the dilemma of donor-positive/recipient-negative serostatus
    Robin K Avery
    Clin Infect Dis 45:448-9. 2007
  35. ncbi request reprint Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients
    Hina Sahi
    Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Heart Lung Transplant 26:350-6. 2007
    ..Infection is associated with a high rate of dissemination and poor outcome overall...
  36. ncbi request reprint Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients
    Nell S Lurain
    Department of Immunology Microbiology, Rush Presbyterian St Luke s Medical Center, Chicago, IL 60612, USA
    J Infect Dis 186:760-8. 2002
    ....
  37. ncbi request reprint The impact of hypogammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation
    Mohamad H Yamani
    Department of Cardiovascular Medicine, Kaufman Center for Heart Failure, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Heart Lung Transplant 25:820-4. 2006
    ..However, to our knowledge, quantitative immunoglobulin G (IgG) level determination and the impact of hypogammaglobulinemia (HGG) on infections after VAD implantation have not been evaluated before...
  38. ncbi request reprint Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients
    Roy F Chemaly
    Department of Pathology, Section of Clinical Microbiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Am J Transplant 5:544-8. 2005
    ..High CMV VL in BAL in lung transplant recipients is strongly associated with CMV pneumonitis, and may be more predictive than peripheral blood viral load...
  39. ncbi request reprint Can donors with prior hepatitis be safely used for heart transplantation?
    Steven D Mawhorter
    Department of Infectious Disease, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Heart Lung Transplant 25:805-13. 2006
    ..With the severe shortage of available organs and significant waiting list mortality there is a rationale for considering use of organs from donors with evidence of prior hepatitis B and/or hepatitis C infection...
  40. ncbi request reprint Donor or recipient hepatitis B seropositivity is associated with allograft vasculopathy
    Showkat A Haji
    Department of Cardiology, Tulane University Medical Center, New Orleans, Louisiana 70112, USA
    J Heart Lung Transplant 25:294-7. 2006
    ..The current study hypothesized that hepatitis B (HBV) might be associated with accelerated vasculopathy...
  41. ncbi request reprint Fatal West Nile Virus infection after rituximab/fludarabine--induced remission for non-Hodgkin's lymphoma
    Steven D Mawhorter
    Department of Infectious Disease, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Clin Lymphoma Myeloma 6:248-50. 2005
    ..We present a case in which serology results were persistently negative because the patient was immunocompromised following lymphoma treatment. The role of humoral immunity in resolution of WNV is also discussed...
  42. ncbi request reprint Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation
    Showkat A Haji
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Heart Lung Transplant 23:277-83. 2004
    ..We evaluated the hypothesis that donor HCV seropositivity predicts mortality and the development of coronary vasculopathy in cardiac transplant recipients...
  43. ncbi request reprint Cardiac-allograft vasculopathy
    Robin K Avery
    Department of Infectious Disease and Transplant Center, Cleveland Clinic Foundation, Cleveland, USA
    N Engl J Med 349:829-30. 2003
  44. ncbi request reprint Encephalitis owing to human herpesvirus-6 after cardiac transplant
    Patrick J Nash
    Department of Cardiovascular Medicine, Cleveland Clinical Foundation, Cleveland, OH, USA
    Am J Transplant 4:1200-3. 2004
    ..He was treated with foscarnet with gradual improvement in clinical status. We review the literature on the significance of this virus post cardiac transplant...
  45. ncbi request reprint Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant
    Sherif B Mossad
    Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, OH, 44195, USA
    Clin Infect Dis 36:1503-4; author reply 1504. 2003
  46. ncbi request reprint Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi
    Shahid Husain
    University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    Clin Infect Dis 37:221-9. 2003
    ..Thus, non-Aspergillus molds have emerged as significant pathogens in organ transplant recipients. These molds are more likely to be associated with disseminated infections and to be associated with poorer outcomes than is aspergillosis...
  47. ncbi request reprint Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients
    Nina Singh
    Infectious Disease Section, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15240, USA
    Clin Infect Dis 36:46-52. 2003
    ....
  48. ncbi request reprint Daptomycin-resistant Enterococcus faecium in a patient with acute myeloid leukemia
    Jennifer K Long
    Department of Pharmacy, Clinical Microbiology Section, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Mayo Clin Proc 80:1215-6. 2005
    ..No enterococcal cross-resistance has been reported among daptomycin, linezolid, or quinupristin-dalfopristin, and these agents may be viable alternatives...
  49. ncbi request reprint BK virus and renal dysfunction: not limited to kidney transplantation?
    Robin K Avery
    Clin Infect Dis 41:1726-7. 2005
  50. ncbi request reprint Endobronchial fungal disease: an under-recognized entity
    Demet Karnak
    Department of Chest Diseases, Ankara University School of Medicine, Ankara, Turkey, and Department of Chest Medicine, KEM Hospital, Mumbai, India
    Respiration 74:88-104. 2007
    ..EBFI should be included in the differential diagnosis of any form of airway lesions in immunocompromised patients, especially among residents from the endemic areas...